Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 04, 2013 08:24 ET | Source: Hemispherx Biopharma, Inc.

Director of the U.S. Department of Homeland Security Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD), Professor J. Richt, DVM, Ph.D., to Present Programs to Potentially Reduce Pandemic Influenza Spread

PHILADELPHIA, Sept. 4, 2013 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT: HEB) announced that one of its advanced stage biological products, Alferon N Injection®, will be featured as...
September 03, 2013 16:05 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma to Present at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th

PHILADELPHIA, Sept. 3, 2013 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB), today announced it will be featured as a presenting company at the 15th Annual Rodman & Renshaw Global...
August 26, 2013 08:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Announces Biosecurity Program to Potentially Reduce Pandemic Influenza Threat

PHILADELPHIA, Aug. 26, 2013 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE:HEB) announced that at the 2nd International Conference on Biodefense and Natural Disasters meeting in Orlando, FL on August...
August 20, 2013 11:21 ET | Source: Hemispherx Biopharma, Inc.

Director of the U.S. Department of Homeland Security Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD), Professor J. Richt, DVM, Ph.D., to Present Programs to Reduce - Influenza Spread

PHILADELPHIA, Aug. 20, 2013 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) announced that one of its advanced stage biological products, Alferon N®, will be featured as part of a new...
August 09, 2013 16:23 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Announces Financial Results for the Three Months Ended June 30, 2013

PHILADELPHIA, Aug. 9, 2013 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE:HEB) announced its financial results for the three months ended June 30, 2013. The net loss (including non-cash effects) was...
July 29, 2013 08:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Appoints Peter W. Rodino III, Esq. to the Board of Directors and to Serve as Chairman of the Company's Audit Committee

PHILADELPHIA, July 29, 2013 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced that effective July 23, 2013, the Board of Directors of Hemispherx...